Conference Coverage: BMT Tandem Meetings

Conference Coverage

KD025 shows promise for steroid-dependent cGVHD

SALT LAKE CITY – The ROCK2-selective inhibitor KD025 is demonstrating encouraging activity and safety in steroid-dependent cGVHD in a phase 2a...

Pages